Global Osteoarthritis Pain Drugs market Size by Type, End User and Application: Global
Opportunity Analysis and Industry Forecast, 2020-2025. The base year considered for the study is
2020, and the forecast has been provided for the period from 2020 to 2025.
The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of
osteoarthritis, osteoarthritis in the use of two kinds of painkillers: Painkillers only: Only a simple
analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol.
Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate
pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side
effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the
acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs
may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of
gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs
should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are
injected into a joint. Osteoarthritis, the most common type of arthritis, is a leading cause of
disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual
destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical
and morphological changes in the synovial membrane and joint capsule. This results in pain and
loss of movement.
The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven
manufacturers accounts about 88% of the total revenue in 2019. The high-end products mainly
come from USA and Europe.